Enlivex Therapeutics
ENLV
ENLV
22 hedge funds and large institutions have $2.89M invested in Enlivex Therapeutics in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
39% less capital invested
Capital invested by funds: $4.75M → $2.89M (-$1.86M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
22
Holding in Top 10
–
Calls
$532K
Puts
$196K
Top Buyers
| 1 | +$50.4K | |
| 2 | +$19K | |
| 3 | +$3.15K | |
| 4 |
Renaissance Technologies
New York
|
+$2.26K |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.04K |
Top Sellers
| 1 | -$518K | |
| 2 | -$294K | |
| 3 | -$205K | |
| 4 |
Belvedere Trading
Chicago,
Illinois
|
-$101K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$88.7K |